Skip to content
  • origimm
  • Skin Microbiome
  • Indications
    • Acne Vulgaris
    • Background
    • Solution
    • Implant-Associated Infections
    • Background
    • Solution
  • For Partners
  • For Patients
    • Acne Patients
    • Our motivation
    • Answers to frequent questions
  • About us
    • Company
    • Our vision
    • Management board
    • News
    • Join us
    • Open positions
    • Stakeholders
  • Contact
    • Contact
    • Location

Opening of the new R&D facility

Posted on October 21, 2017February 21, 2019 by Origimm Biotechnology in Corporate News

Post navigation

Previous Post New Chief Development Officer
Next Post Additional research funds
  • Home
  • Skin Microbiome
  • Indications
  • For Partners
  • For Patients
  • About us
  • Contact
  • Legal notice
  • Data privacy statement
protected by Google reCAPTCHA - Privacy Policy - Terms of Use // Webdesign: mausblau.at
By continuing to browse the site you are agreeing to our use of cookies. More about cookies and the protection of your data: Data privacy statement